Latest Headlines
-
Avance Clinical Appoints Liahna Toy To Lead Global Early Phase Center Of Excellence
3/23/2026
Avance Clinical, a global full-service CRO headquartered in Australia dedicated to servicing biotech, announces the appointment of Liahna Toy as Senior Vice President & Head of Early Phase Center of Excellence, reinforcing the company’s strategic focus on accelerating high-quality early-phase trials for emerging biotech sponsors.
-
Avance Clinical Strengthens Global Oncology Offering With Acquisition Of U.S-Based LumaBridge
3/23/2026
Avance Clinical, a global contract research organization focused on accelerating clinical development for biotech sponsors, today announced the acquisition of LumaBridge, a specialized U.S.-based clinical CRO with deep expertise in oncology trials.
- Experience Safer Pharmaceutical Processing With Esco Lifesciences At INTERPHEX 2026 3/20/2026
- Discover Safer, Smarter Pharmaceutical Processing With Esco Lifesciences 3/20/2026
-
Vericel Announces FDA Approval Of New State-Of-The-Art Advanced Therapy Manufacturing Facility
3/6/2026
Vericel Corporation, a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that the U.S. Food and Drug Administration (FDA) has granted approval for MACI® (autologous cultured chondrocytes on porcine collagen membrane) commercial manufacturing at its state-of-the-art cell therapy manufacturing facility in Burlington, Massachusetts.
-
Minaris Launches AgentSCREEN Adventitious Virus Detection By NGS To Simplify Viral Safety Testing For Cell Banks And Cell-Based Samples
3/4/2026
Minaris, a global cell and gene therapy (CGT) contract development and manufacturing organization (CDMO) and multimodality biosafety testing provider, today announced the launch of AgentSCREEN Adventitious Virus Detection by Next Generation Sequencing (NGS).
- Join Esco At INTERPHEX 2026 3/3/2026
-
Ensorcell Appoints Biopharma Industry Veterans Geoff Hodge And Amy Teachout To Senior Leadership Team
3/3/2026
Ensorcell, a company focused on reimaging life science tools and solutions for the biopharmaceutical industry, today announced the appointment of Geoff Hodge and Amy Teachout to its senior leadership team. These appointments reinforce Ensorcell’s commitment to innovation, superb value, and exceptional customer experience as the company continues to expand its capabilities and partnerships across the biopharma ecosystem.
-
Novartis Announces New Radioligand Therapy Manufacturing Facility In Denton, Texas
2/26/2026
Novartis, a leading global innovative medicines company, today announced plans to establish a new 46,000-square-foot radioligand therapy (RLT) manufacturing site in Denton, Texas.
-
Andelyn Biosciences To Apply the AAV CuratorĀ® Platform To Manufacture Clinical Grade AAV For Drake Rayden Foundation For The Treatment Of Nonketotic Hyperglycinemia
2/25/2026
Andelyn Biosciences, Inc., a leading and patient-focused cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has been selected by Drake Rayden Foundation to apply the AAV Curator® Platform to manufacture clinical grade AAV for the Treatment of Nonketotic Hyperglycinemia (NKH), a rare, inherited metabolic genetic disorder caused by a mutation in the GLDC gene.